These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 460818)
21. Antibodies in bovine serum and lacteal secretions to capsular antigens of Staphylococcus aureus. Opdebeeck JP; Norcross NL Am J Vet Res; 1985 Jul; 46(7):1561-4. PubMed ID: 4026041 [TBL] [Abstract][Full Text] [Related]
22. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage. Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513 [TBL] [Abstract][Full Text] [Related]
23. Immunization of mice and calves against Salmonella dublin with attenuated live and inactivated vaccines. Cameron CM; Fuls WJ Onderstepoort J Vet Res; 1976 Jun; 43(2):31-7. PubMed ID: 1018887 [TBL] [Abstract][Full Text] [Related]
24. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
25. A vaccine to prevent infections with Staphylococcus aureus. Thiemermann C Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409 [No Abstract] [Full Text] [Related]
26. Antibody response in lacteal secretions of cows after immunization with various concentrations of staphylococcal and streptococcal antigens. Opdebeeck JP; Norcross NL Am J Vet Res; 1982 Oct; 43(10):1770-5. PubMed ID: 6756223 [TBL] [Abstract][Full Text] [Related]
27. Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Buzzola FR; Barbagelata MS; Caccuri RL; Sordelli DO Infect Immun; 2006 Jun; 74(6):3498-506. PubMed ID: 16714581 [TBL] [Abstract][Full Text] [Related]
28. Response of sheep and cattle to combined polyvalent Pasteurella haemolytica vaccines. Cameron CM; Bester FJ Onderstepoort J Vet Res; 1986 Mar; 53(1):1-7. PubMed ID: 3960485 [TBL] [Abstract][Full Text] [Related]
29. [Preparation of delayed-action staphylococcal vaccine. I. Effect of the vaccine on local skin infection in rabbits]. Giedrys-Galant S; Hałasa J; Podkowińska I Med Dosw Mikrobiol; 1984; 36(2):77-85. PubMed ID: 6492938 [No Abstract] [Full Text] [Related]
30. Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Projan SJ; Nesin M; Dunman PM Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507 [TBL] [Abstract][Full Text] [Related]
31. [An experimental study of humoral immunity factors in immunization with a cell-free staphylococcal vaccine]. Kuz'mina LA; Kozlova NN Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):44-5. PubMed ID: 8553749 [No Abstract] [Full Text] [Related]
32. Effective immunization of lambs against enterotoxaemia. Cameron CM Onderstepoort J Vet Res; 1980 Dec; 47(4):287-9. PubMed ID: 7231926 [TBL] [Abstract][Full Text] [Related]
33. The effect of intramuscular and intramammary vaccination of cows on antibody levels and resistance to intramammary infection by Staphylococcus aureus. Brock JH; Steel ED; Reiter B Res Vet Sci; 1975 Sep; 19(2):152-8. PubMed ID: 1166119 [TBL] [Abstract][Full Text] [Related]
34. [Controversy in asthma. II. A new vaccine prepared with the Cowan I strain of Staphylococcus aureus]. del Real Sánchez JH Rev Alerg Mex (1987); 1987; 34(4):99-105. PubMed ID: 3324814 [No Abstract] [Full Text] [Related]
35. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Dayan GH; Mohamed N; Scully IL; Cooper D; Begier E; Eiden J; Jansen KU; Gurtman A; Anderson AS Expert Rev Vaccines; 2016 Nov; 15(11):1373-1392. PubMed ID: 27118628 [TBL] [Abstract][Full Text] [Related]
36. Isolation and properties of a surface antigen of Staphylococcus aureus. MORSE SI J Exp Med; 1962 Feb; 115(2):295-311. PubMed ID: 14476344 [TBL] [Abstract][Full Text] [Related]
37. Deciphering the significance of the T-cell response to Staphylococcus aureus. Bekeredjian-Ding I Future Microbiol; 2017 Sep; 12():1023-1026. PubMed ID: 28748708 [No Abstract] [Full Text] [Related]
38. Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. McNeely TB; Shah NA; Fridman A; Joshi A; Hartzel JS; Keshari RS; Lupu F; DiNubile MJ Hum Vaccin Immunother; 2014; 10(12):3513-6. PubMed ID: 25483690 [TBL] [Abstract][Full Text] [Related]
39. [Characteristics of antigenic complexes of Staphylococcus aureus vaccine strains obtained in different cultivation conditions]. Kuz'menko OM; Zlygostev SA; Mikhaĭlova NA; Gruber IM; Akhmatova NK; Egorova NB; Kurbatova EA; Cherkasova LS Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):51-4. PubMed ID: 20465001 [TBL] [Abstract][Full Text] [Related]
40. [Sensitizing and protective activity of a staphylococcal vaccine made of water-soluble antigens, depending on the method and schedule of administration]. Efremova VN; Kuz'mina LA; Moshiashvili IIa Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):16-9. PubMed ID: 3993287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]